Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145

Pathology and Oncology Research

Volumn 22, Issue 4, 2016, Pages 733-740

  Zhou, Peng ^a   Sun, Lixia ^a   Liu, Danfeng ^a   Liu, Changkuo ^a   Sun, Lei ^a  

^a The Second People's Hospital of Wuhu   (China)

Author keywords

Colon cancer; lincRNA ROR; miR 145; Oncogene

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; LONG NON CODING RNA ROR; LONG UNTRANSLATED RNA; MICRORNA 145; UNCLASSIFIED DRUG; MICRORNA; MIRN145 MICRORNA, HUMAN;

ADULT; AGE; AGED; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL OUTCOME; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENDER; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; CELL MOTION; COLON TUMOR; DISEASE COURSE; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RNA, LONG NONCODING;

EID: 84963664612     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-016-0061-x     Document Type: Article

References (32)

1. Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383:1490–1502
2. Sieqel R, Desantis C, Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64:104–117
3. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. (2010) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573
4. Jankowski JA, Odze RD (2009) Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 104:1093–1096
5. Modjtahedi H, Essapen S (2009) Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opporunities. Anti-Cancer Drugs 20:851–855
6. Aslam MI, Taylor K, Pringle JH, Jameson JS (2009) MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 96:702–710
7. Kiersem JB, Iksahl T, Lingjaerde OC, Guren T, Tveit KM, Kure EH (2014) Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment. Mol Oncol 8:59–67
8. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y, et al. (2013) Long noncoding RNA CCAT1, which coild be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol 139:437–445
9. Zhang EB, Yin DD, Sun M, Kong R, Liu XH, You LH, et al. (2014) P53-regulated long non- coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 5:e1243
10. Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren X, et al. (2015) Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol 46:2586–2594
11. Wang L, Cai Y, Zhao X, Jia X, Zhang J, Liu J, et al. (2015) Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma. Neoplasma 62:412–418
12. Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–361
13. Khalil AM, Guttman M, Huarte M, Garber M, Rai A, Rivea Morales D, et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106:11667–11672
14. Guttman M, Rinn JL (2012) Modular regulatory principles of large non-coding RNAs. Nature 482:339–346
15. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, et al. (2013) Endogenous miRNA sponge lincRNA-ROR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 25:69–80
16. Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q (2015) LincRNA-ROR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res 13:330–338
17. Zhou X, Gao Q, Wang J, Zhang X, Liu K, Duan Z (2014) Linc-RNA-ROR acts as a “spong” against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol 133:333–339
18. Iguchi T, Uchi R, Nambara S, Saito T, Komatsu H, Hirata H, et al. (2015) A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res 35:1385–1388
19. Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin L, et al. (2014) Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol 7:63
20. Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang M, Wang CJ, et al. (2015) HOTAIR long noncoding RNA promotes gastric cancer metastasis through suppression of poly r(c)-binding protein (PCBP) 1. Mo Cancer Ther 14:1162–1170
21. Wu Y, Liu H, Shi X, Yao Y, Yang W, Song Y (2015) The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget 6:9160–9172
22. Lee H, Kim C, Ku JL, Kim W, Yoon SK, Kuh HJ, et al. (2014) A long non-coding RNA snaR contributes to 5- fluorouracil resistance in human colon cancer cells. Mol Cell 37:540–546
23. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, et al. (2010) Large intergenic non-coding RNA-ROR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42:1113–1117
24. Takahashi K, Yan IK, Koqure T, Haqa H, Patel T (2014) Exreacellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio 4:458–467
25. Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y, et al. (2014) LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 5:e1287
26. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146:353–358
27. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, et al. (2011) Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147:344–357
28. Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL, Chang YC, et al. (2013) miR-145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res 73:3425–3440
29. Noh JH, Chang YG, Kim MG, Jung KH, Kim JK, Bae HJ, et al. (2013) MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett 335:455–462
30. Zhang Y, Lin Q (2015) MicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancer. Int J Clin Exp Med 8:8794–8802
31. Qin J, Wang F, Jiang H, Xu J, Jiang Y, Wang Z (2015) MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. Int J Clin Exp Pathol 8:1328–1340
32. Foltran L, Maglio GD, Pella N, Ermacora P, Aprile G, Masiero E, et al. (2015) Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncol 11:629–640